Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020

IMPORTANCE: Increasingly, cost-effectiveness analyses are being done to determine the value of rapidly increasing oncology drugs; however, this assumes that these analyses are unbiased. OBJECTIVE: To analyze the characteristics of cost-effectiveness studies and to determine characteristics associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslam, Alyson, Lythgoe, Mark P., Greenstreet Akman, Emma, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603079/
https://www.ncbi.nlm.nih.gov/pubmed/34792592
http://dx.doi.org/10.1001/jamanetworkopen.2021.35123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603079/
https://www.ncbi.nlm.nih.gov/pubmed/34792592
http://dx.doi.org/10.1001/jamanetworkopen.2021.35123

Ejemplares similares